Jencycla Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Jencycla
H
- Hadlima (adalimumab)
- Haponal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Hecoria (tacrolimus)
- Hulio (adalimumab)
- Humalog (insulin lispro)
- Humalog Junior KwikPen (insulin lispro)
- Humalog KwikPen (insulin lispro)
- Humalog Mix 50/50 (insulin lispro/insulin lispro protamine)
- Humalog Mix 50/50 KwikPen (insulin lispro/insulin lispro protamine)
- Humalog Mix 75/25 (insulin lispro/insulin lispro protamine)
- Humalog Mix 75/25 KwikPen (insulin lispro/insulin lispro protamine)
- Humatrope (somatropin)
- HumatroPen (somatropin)
- Humira (adalimumab)
- Humulin 50 / 50 (insulin isophane / insulin regular)
- Humulin 70 / 30 (insulin isophane / insulin regular)
- Humulin 70 / 30 Pen (insulin isophane / insulin regular)
- Humulin L (insulin zinc)
- Humulin N (insulin isophane)
- Humulin N Pen (insulin isophane)
- Humulin R (insulin regular)
- Humulin R U-500 (Concentrated) (insulin regular)
- Humulin R U-500 KwikPen (insulin regular)
- Humulin U (insulin zinc extended)
- Hydrophed (ephedrine / hydroxyzine / theophylline)
- Hydroxy Compound (ephedrine / hydroxyzine / theophylline)
- hyoscyamine / phenobarbital
- Hyosophen (atropine / hyoscyamine / phenobarbital / scopolamine)
- Hyrimoz (adalimumab)
More about Jencycla (norethindrone)
- Jencycla consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (74)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.